• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Startup That Focuses on Metabolic Reset Calibrate Scores $22.5M in Series a Funding

Share:

January 28, 2021

Weight management platform Calibrate announced a $22.5 million in Series A led by Threshold Ventures, with participation from Forerunner Ventures and Redesign Health.

This comes roughly six months after the company launched with a $5.1 million boost in seed funding from Forerunner.

WHAT IT DOES

Calibrate’s goal is to help its users reset their metabolism. Users start the program by getting a workup of labs and having a telemedicine visit with a doctor. The doctor can then prescribe drugs based on the visit and labs.

The program combines telemedicine for behavioral therapy with medication. Each user is matched with a weight coach who can help them change their daily habits to include healthier eating and more exercise.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Users also get a connected smart scale and app to track their weight and daily habits. The program can then be tailored to each individual and small “tweaks” are recommended. The user is given more strategies along the way, according to Calibrate’s website.

WHAT IT’S FOR

The company plans on using the new funds to grow its business.

“This investment will allow us to continue to expand our technology platform, powering the delivery of best-in-class clinical outcomes through compelling consumer product, purpose-built tools for integrated clinical care and coaching, and the data infrastructure for real-world evidence,” Isabelle Kenyon, Founder & CEO at Calibrate, said in a statement.

MARKET SNAPSHOT

It’s no secret that a lot of folks are struggling with weight management. In fact, according to the CDC, the U.S. obesity rate is 42.4%. As a result, many companies are looking at the space.

In January, Weight Watchers released its new immersive digital membership plan called Digital 360, which gives users access to on-demand and live coaching, as well an online community of peers and online events.

Ro, a direct-to-consumer virtual health company, added a new weight-management offering. Its doctors are now able to prescribe Plenity, an ingestible weight-management product.

Other names in the digital dieting space include Loose It!, and Suggestic.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Mayo Clinic in Florida Uses Autonomous Vehicles to Transport COVID-19 Test SamplesMayo Clinic in Florida Uses Autonomous Vehicles to Transport COVID-19 Test Samples
  • Medline Expands Respiratory Solutions with AG Cuffill AcquisitionMedline Expands Respiratory Solutions with AG Cuffill Acquisition
  • Ziylo Acquired by Novo Nordisk in Deal That Could Exceed US$800mZiylo Acquired by Novo Nordisk in Deal That Could Exceed US$800m
  • LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New YorkLOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York
  • LIFE SCIENCES SOFTWARE MARKET TO GAIN SUBSTANTIAL TRACTION THROUGH 2026LIFE SCIENCES SOFTWARE MARKET TO GAIN SUBSTANTIAL TRACTION THROUGH 2026
  • Israeli Startup Uses AI to Identify Healthy Embryos and Increase IVF SuccessIsraeli Startup Uses AI to Identify Healthy Embryos and Increase IVF Success
  • VC Firm Bioluminescence Ventures Launches with $477M in AssetsVC Firm Bioluminescence Ventures Launches with $477M in Assets
  • New York regulator has concerns on CVS dealNew York regulator has concerns on CVS deal

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications